Understanding the cellular pathways regulated by Dis3L2 in cell proliferation.
Understanding the cellular pathways regulated by Dis3L2 in cell proliferation.
批准号:
BB/P021042/1
负责人:
Sarah Newbury
金额:
$54.57万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Regulation of cell proliferation is of crucial importance to all multicellular organisms. Cells must proliferate throughout development in order for the organism to grow from an egg to an adult. Proliferation must also occur to repair damaged areas during the process of wound healing. Control of proliferation is vitally important to allow individual animals and their constituent organs to grow to reach and not exceed their correct sizes, as well as to maintain symmetry between the left and right sides of an animal. Uncontrolled cell proliferation is a hallmark of cancer with many genes involved in growth and proliferation implicated in cancer progression. Using fruit flies as a model organism, we have recently discovered that cell proliferation can be regulated by an enzyme named Dis3L2. This enzyme is known to destroy messenger RNA molecules (mRNAs) which instruct the cell to make particular proteins. By comparing mutant fruit flies lacking Dis3L2 with normal individuals, we have found that lack of Dis3L2 results in wings that are much larger than normal. The wings grow from larval wing imaginal discs, which are also much larger in the mutant. Our results are particularly interesting because mutations in the equivalent human gene, DIS3L2, result in Perlman syndrome and susceptibility to a kidney cancer called Wilms' tumour. Perlman syndrome is an overgrowth condition where affected children display pre-natal gigantism and abnormal enlargement of organs (e.g. kidneys). Therefore mutations in Dis3L2 in both fruit flies and humans result in the overgrowth of cells within some organs, showing an excellent conservation of this biological pathway between these organisms and demonstrating the usefulness of fruit flies to understand this disease.Using state-of-the-art molecular methods, we have discovered that a lack of Dis3L2 results in an increase in levels of a few specific mRNAs. The known function of some of these mRNAs suggest a molecular pathway for understanding the function of Dis3L2 in flies and humans. Our hypothesis is that Dis3L2 normally controls proliferation by limiting energy production within the cell as well as regulating the levels of important cellular resources. Since proliferating cells require more energy to fuel their rapid growth, this hypothesis is consistent with the tissue overgrowth we see in our fruit flies. We have the expertise, as well as the molecular and genetic tools to test this hypothesis. The proposed project is entirely novel; as yet no research group has elucidated the mechanisms whereby Dis3L2 controls proliferation in the natural context of a developing organism. Previous studies have used individual tissue culture cells or immortalised cells in culture rather than normal cells in a natural tissue therefore have missed clues about the cellular pathways involved. Since the cellular pathways controlling growth in fruit flies are very similar to those in humans, the knowledge gained during this project may help us to to understand the ways that normal tissues grow and develop. This knowledge will also be useful in finding ways to promote controlled regeneration of tissues such as that which occurs during liver regeneration. It will also be important in the search for therapies to combat uncontrolled proliferation, as occurs during cancer. Should our experiments confirm that Dis3L2 controls proliferation via metabolic pathways, this will provide a powerful way of combatting cancer as it will be difficult for cancer cells to circumvent their need for high metabolic rates. This project will therefore provide valuable insights into a new cellular pathway which can be used in the development of new disease therapeutics.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Potential of Non-Coding RNA as Biomarkers for Progressive Supranuclear Palsy.
非编码 RNA 作为进行性核上性麻痹生物标志物的潜力。
DOI:
10.17863/cam.92654
发表时间:
2022
期刊:
影响因子:
--
作者:
[Simoes F]
通讯作者:
Simoes F
DOI:
10.1080/07853890.2022.2138530
发表时间:
2022-12
期刊:
Annals of medicine
影响因子:
4.4
作者:
[]
通讯作者:
DOI:
10.3390/biom8020021
发表时间:
2018-04-26
期刊:
Biomolecules
影响因子:
5.5
作者:
[Mumford SL, Towler BP, Pashler AL, Gilleard O, Martin Y, Newbury SF]
通讯作者:
Newbury SF
DOI:
10.3389/fgene.2024.1272689
发表时间:
2024-02-20
期刊:
FRONTIERS IN GENETICS
影响因子:
3.7
作者:
[Bernard,Elisa I. M., Towler,Benjamin P., Newbury,Sarah F.]
通讯作者:
Newbury,Sarah F.
DOI:
10.1261/rna.078872.121
发表时间:
2021-10
期刊:
RNA (New York, N.Y.)
影响因子:
--
作者:
[Pashler AL, Towler BP, Jones CI, Haime HJ, Burgess T, Newbury SF]
通讯作者:
Newbury SF
共 7 条
Unlocking the molecular and cellular mechanisms regulated by the ribonuclease Dis3L2 in Drosophila and human cell proliferation.
-
批准号:BB/V001701/1
-
项目类别:Research Grant
-
资助金额:$60.49万
-
财政年份:2021
-
负责人:Sarah Newbury
-
依托单位:
Epigenetic regulation of gene expression by the exoribonuclease pacman
-
批准号:BB/I021345/1
-
项目类别:Research Grant
-
资助金额:$56.98万
-
财政年份:2011
-
负责人:Sarah Newbury
-
依托单位:
Targeted mRNA degradation in Drosophila spermatogenesis
-
批准号:BB/I007989/1
-
项目类别:Research Grant
-
资助金额:$55.21万
-
财政年份:2011
-
负责人:Sarah Newbury
-
依托单位:
Function of the exoribonuclease pacman in cell movement and cell shape change
-
批准号:BB/G002754/1
-
项目类别:Research Grant
-
资助金额:$53.28万
-
财政年份:2008
-
负责人:Sarah Newbury
-
依托单位:
Analysis of the role of ribonucleases in the regulation of epithelial sheet sealing
-
批准号:BB/C005163/2
-
项目类别:Research Grant
-
资助金额:$19.34万
-
财政年份:2007
-
负责人:Sarah Newbury
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于MFSD2A调控血迷路屏障跨细胞囊泡转运机制的噪声性听力损失防治研究
-
批准号:82371144
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:汪雪玲
-
依托单位:
长寿基因SIRT7调控核苷酸切除修复通路的机制研究
-
批准号:32100605
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:耿安珂
-
依托单位:
溶酶体蛋白LAPTM4B通过与Xc-系统相互作用调控谷胱甘肽代谢的机制研究
-
批准号:32100623
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:周可成
-
依托单位:
小鼠肺分支早期发育中肺上皮单细胞的时-空转录组的建立与分析
-
批准号:32070795
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:蔡军
-
依托单位:
乳腺癌上皮间质转化中核苷酸代谢相关的功能蛋白发现和机理研究
-
批准号:32070748
-
项目类别:面上项目
-
资助金额:54.0万元
-
批准年份:2020
-
负责人:戴凌云
-
依托单位:
rhTβ4增强间充质干细胞调节T细胞代谢重塑治疗干眼的机制研究
-
批准号:32000530
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:陈小鸟
-
依托单位:
胰岛素和细菌信号协同调节巨噬细胞免疫反应的作用
-
批准号:92057105
-
项目类别:重大研究计划
-
资助金额:89.0万元
-
批准年份:2020
-
负责人:Tiffany Shy Yea Horng
-
依托单位:
胞浆甘氨酰-tRNA合成酶cytoGARS感知甘氨酸的分子机制及其对肝细胞癌的影响
-
批准号:32070756
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2020
-
负责人:汪维
-
依托单位:
葡萄糖调节的AXIN溶酶体膜转运的分子机制
-
批准号:32070753
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2020
-
负责人:李梦琪
-
依托单位:
一种全新的高尔基体胆固醇感应蛋白的鉴定和功能研究
-
批准号:32070755
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:钟辉
-
依托单位: